Section Arrow
FBLG.NASDAQ
- FibroBiologics
(Financial Status)
Quotes are at least 15-min delayed:2026/01/01 05:00 EST
Regular Hours
Last
 0.2249
-0.017 (-7.03%)
Day High 
0.2694 
Prev. Close
0.2419 
1-M High
0.409 
Volume 
21.65M 
Bid
0.221
Ask
0.23
Day Low
0.2212 
Open
0.2693 
1-M Low
0.2201 
Market Cap 
16.09M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.25 
20-SMA 0.27 
50-SMA 0.32 
52-W High 2.335 
52-W Low 0.2201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.48/-0.34
Enterprise Value
17.08M
Balance Sheet
Book Value Per Share
0.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4167+0.0462+12.47%-- 
OTLKOutlook Therapeutics1.58-0.285-15.28%0.58PE
VNDAVanda Pharmaceuticals8.82+1.79+25.46%126.25PE
SLSSELLAS Life Sciences Group3.77+0.46+13.90%-- 
FBLGFibroBiologics0.2249-0.017-7.03%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.